Bionano Genomics Inc. (NASDAQ:BNGO) stock has tumbled to a 52-week low, touching down at $4.9 as the company faces a challenging market environment. According to InvestingPro data, the stock's RSI ...

The company, founded by 25-year-old Kian Sadeghi, announced a $14 million Series A, bringing its total funding to about $32 million.

MIT chemists use generative AI to predict 3D genomic structures quickly, a process far faster than current methods.

Figuring out how your genes and environment increase your likelihood of developing asthma, heart disease, cancer, dementia ...

A team of investigators from Dana-Farber Cancer Institute, The Broad Institute of MIT and Harvard, Google, and Columbia ...

ATx has created groundbreaking drugs for dementia and Alzheimer’s. The Icelandic startup just raised €26mn to advance the ...

A significant advancement in knowledge of the link between cognition and genetics has been made thanks to a study led by ...

M42 signals genomics expansion with strategic partnership with Uzbekistan’s Ministry of Health on the Uzbek Genome Program ...

Farmers have the chance to explore the fascinating world of genomics with the help of an expert panel of leading crop ...

Moss Genomics Inc. (CSE: MOSS) (FSE: F73) (the "Company" or "Moss") is pleased to announce a non-brokered private placement of up to ...